Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trial

MLA

Joachim Gerss, et al. “Biomarker-Guided Intervention to Prevent Acute Kidney Injury after Major Surgery (BigpAK-2 Trial): Study Protocol for an International, Prospective, Randomised Controlled Multicentre Trial.” BMJ Open, vol. 13, no. 3, Mar. 2023. EBSCOhost, https://doi.org/10.1136/bmjopen-2022-070240.

APA

Joachim Gerss, Javier Ripollés-Melchor, Emmanuel Futier, Melanie Meersch, Carola Wempe, Detlef Kindgen-Milles, Alexander Zarbock, Markus W Hollmann, Sigismond Lasocki, Thomas Rimmele, Tim Rahmel, Michael Adamzik, Hartmuth Nowak, Ingeborg Welters, Brian Johnston, Ane Abad-motos, Alfredo Abad-gurumeta, Marc Moritz Berger, Davide Ricci, … Marion Leclercq-Rouget. (2023). Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trial. BMJ Open, 13(3). https://doi.org/10.1136/bmjopen-2022-070240

Chicago

Joachim Gerss, Javier Ripollés-Melchor, Emmanuel Futier, Melanie Meersch, Carola Wempe, Detlef Kindgen-Milles, Alexander Zarbock, et al. 2023. “Biomarker-Guided Intervention to Prevent Acute Kidney Injury after Major Surgery (BigpAK-2 Trial): Study Protocol for an International, Prospective, Randomised Controlled Multicentre Trial.” BMJ Open 13 (3). doi:10.1136/bmjopen-2022-070240.